ArticleOncoTargets and therapy2020

Downstaging of Recurrent Advanced Hepatocellular Carcinoma After Lenvatinib Treatment: Opportunities or Pitfalls? A Case Report.

Zhaobo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.